Analysts Set Ryan Specialty Holdings, Inc. (NYSE:RYAN) PT at $74.40

Ryan Specialty Holdings, Inc. (NYSE:RYAN) has earned an average rating of “Hold” from the twelve brokerages that are presently covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and six have issued a buy recommendation on the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $74.40.

Several research analysts have recently weighed in on the stock. Wells Fargo & Company decreased their price target on shares of Ryan Specialty from $68.00 to $64.00 and set an “equal weight” rating on the stock in a report on Tuesday, January 14th. Keefe, Bruyette & Woods decreased their target price on Ryan Specialty from $79.00 to $77.00 and set an “outperform” rating on the stock in a research note on Friday, January 10th. Morgan Stanley assumed coverage on Ryan Specialty in a research report on Thursday, December 5th. They set an “overweight” rating and a $90.00 price target for the company. Finally, Barclays upped their price objective on shares of Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a research report on Thursday, November 21st.

Insiders Place Their Bets

In related news, Director David P. Bolger sold 7,055 shares of the firm’s stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $70.88, for a total transaction of $500,058.40. Following the transaction, the director now directly owns 78,149 shares in the company, valued at $5,539,201.12. This trade represents a 8.28 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Nicholas Dominic Cortezi sold 31,409 shares of the business’s stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $65.64, for a total value of $2,061,686.76. Following the completion of the sale, the director now owns 2,697 shares of the company’s stock, valued at $177,031.08. The trade was a 92.09 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 323,506 shares of company stock valued at $21,407,851. 11.10% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in RYAN. Jennison Associates LLC boosted its position in Ryan Specialty by 60.2% during the 3rd quarter. Jennison Associates LLC now owns 1,025,063 shares of the company’s stock valued at $68,054,000 after buying an additional 385,366 shares during the period. JPMorgan Chase & Co. raised its stake in shares of Ryan Specialty by 107.5% during the third quarter. JPMorgan Chase & Co. now owns 459,464 shares of the company’s stock valued at $30,504,000 after acquiring an additional 238,064 shares during the last quarter. Geneva Partners LLC bought a new position in shares of Ryan Specialty during the third quarter valued at about $2,537,000. Bar Harbor Wealth Management boosted its holdings in shares of Ryan Specialty by 5.9% during the fourth quarter. Bar Harbor Wealth Management now owns 168,871 shares of the company’s stock worth $10,835,000 after purchasing an additional 9,482 shares during the period. Finally, Barclays PLC grew its stake in shares of Ryan Specialty by 1.1% in the third quarter. Barclays PLC now owns 1,641,743 shares of the company’s stock worth $108,994,000 after purchasing an additional 17,267 shares during the last quarter. Institutional investors own 84.82% of the company’s stock.

Ryan Specialty Stock Performance

NYSE RYAN opened at $69.55 on Wednesday. The company’s 50 day simple moving average is $65.56 and its two-hundred day simple moving average is $67.23. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. Ryan Specialty has a 1 year low of $45.55 and a 1 year high of $75.97. The stock has a market capitalization of $18.21 billion, a PE ratio of 90.33, a P/E/G ratio of 1.19 and a beta of 0.72.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.